Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
Data from both PRECISION-HD clinical trials expected in 2H 2020 Advancing clinical neurology pipeline − SNP3 and C9orf72 programs on track to initiate clinical development in 2H 2020 First ADAR-mediated RNA-editing data in non-human primates demonstrates …